i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
You will also receive monthly ETF model portfolio and trend trader model portfolio
Two Week FREE Trial
Terms and Conditions
Hemispherx BioPharma, Inc. (AMEX: HEB)
Current Price :
52 Week Low
52 Week High
Opinion and Analysis
Hemispherx Biopharma (HEB) Gains After FDA Accepts Resubmission Regarding Ampligen NDA
Aug 14, 2012 09:15 AM |
Hemispherx And Fountain To Start China Trial Of Flu Drug
May 26, 2010 02:55 PM |
Market Closing Update: Flat Finish For Wall Street As Energy Shares Weigh
Dec 02, 2009 04:50 PM |
More Articles on HEB..
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
Mar 24, 2015 08:30 AM |
Hemispherx Biopharma to Present Data on the Activity of Ampligen(R) Against the Ebola Virus
Mar 23, 2015 08:30 AM |
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2014
Mar 20, 2015 09:28 AM |
More Press Releases on HEB..
Avg. Short Term
Avg. Long Term
Compare to S&P
Join Blog Network
| Copyright 2014 all rights reserved
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
. Advertisement partners
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.